Celldex Therapeutics, Inc. · NASDAQ:CLDX

Point72 Asset Management, L.P. reported a 6.70% stake in Celldex Therapeutics, Inc. (Schedule 13G)

Event Jul 2, 2025 · Filed Jul 10, 2025

Point72 Asset Management, L.P. reported a 6.70% stake in Celldex Therapeutics, Inc., 4,464,400 shares, as a passive investor on Jul 2, 2025. Filed Jul 10, 2025 (Schedule 13G).

Stake
6.70%
Shares
4,464,400
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.6.70%4,464,400
Point72 Capital Advisors, Inc.6.70%4,464,400
Steven A. Cohen6.70%4,464,400

Source

View original at SEC

Related